Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload.

We investigated sex differences and the role of estrogen receptor-beta (ERbeta) on myocardial hypertrophy in a mouse model of pressure overload. We performed transverse aortic constriction (TAC) or sham surgery in male and female wild-type (WT) and ERbeta knockout (ERbeta(-/-)) mice. All mice were characterized by echocardiography and hemodynamic measurements and were killed 9 wk after surgery. Left ventricular (LV) samples were analyzed by microarray profiling, real-time RT-PCR, and histology. After 9 wk, WT males showed more hypertrophy and heart failure signs than WT females. Notably, WT females developed a concentric form of hypertrophy, while males developed eccentric hypertrophy. ERbeta deletion augmented the TAC-induced increase in cardiomyocyte diameter in both sexes. Gene expression profiling revealed that WT male hearts had a stronger induction of matrix-related genes and a stronger repression of mitochondrial genes than WT female hearts. ERbeta(-/-) mice exhibited a different transcriptional response. ERbeta(-/-)/TAC mice of both sexes exhibited induction of proapoptotic genes with a stronger expression in ERbeta(-/-) males. Cardiac fibrosis was more pronounced in male WT/TAC than in female mice. This difference was abolished in ERbeta(-/-) mice. The number of apoptotic nuclei was increased in both sexes of ERbeta(-/-)/TAC mice, most prominent in males. Female sex offers protection against ventricular chamber dilation in the TAC model. Both female sex and ERbeta attenuate the development of fibrosis and apoptosis, thus slowing the progression to heart failure.

[1]  Fen Liu,et al.  Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload‐induced cardiac hypertrophy to heart failure , 2009, Clinical and experimental pharmacology & physiology.

[2]  R. Karas,et al.  Estrogen Attenuates Left Ventricular and Cardiomyocyte Hypertrophy by an Estrogen Receptor–Dependent Pathway That Increases Calcineurin Degradation , 2009, Circulation research.

[3]  V. Regitz-Zagrosek,et al.  Leading article , 1964 .

[4]  M. Vannan,et al.  Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. , 2008, Endocrinology.

[5]  R. Karas,et al.  17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. , 2008, Journal of cardiac failure.

[6]  S. Crosby,et al.  Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. , 2008, Physiological genomics.

[7]  K. Dahlman-Wright,et al.  Review Nuclear Receptor Signaling | The Open Access Journal of the Nuclear Receptor Signaling Atlas Estrogen receptor β: an overview and update , 2022 .

[8]  V. Regitz-Zagrosek,et al.  Estrogens and SERMs in coronary heart disease. , 2007, Current opinion in pharmacology.

[9]  P. Doevendans,et al.  Estrogen Receptor &bgr; Protects the Murine Heart Against Left Ventricular Hypertrophy , 2006 .

[10]  Marc A Pfeffer,et al.  Controversies in ventricular remodelling , 2006, The Lancet.

[11]  James A. Clark,et al.  Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy , 2005 .

[12]  V. Regitz-Zagrosek,et al.  Upregulation of Myocardial Estrogen Receptors in Human Aortic Stenosis , 2004, Circulation.

[13]  R. Karas,et al.  17&bgr;-Estradiol Reduces Cardiomyocyte Apoptosis In Vivo and In Vitro via Activation of Phospho-Inositide-3 Kinase/Akt Signaling , 2004, Circulation research.

[14]  J. Rinn,et al.  Major molecular differences between mammalian sexes are involved in drug metabolism and renal function. , 2004, Developmental cell.

[15]  E. Olson,et al.  Hypertrophy of the heart: a new therapeutic target? , 2004, Circulation.

[16]  Michael O. Griffin,et al.  Gender-related differences in proliferative response of cardiac fibroblasts to hypoxia , 2000, Molecular and Cellular Biochemistry.

[17]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[18]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[19]  N. Freemantle,et al.  The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .

[20]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[21]  D. Lannigan.  Estrogen receptor phosphorylation , 2003, Steroids.

[22]  S. Houser,et al.  Gender differences in post-infarction hypertrophy in end-stage failing hearts. , 2003, Journal of the American College of Cardiology.

[23]  C. Otto,et al.  Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  H. Wellens,et al.  17&bgr;-Estradiol Attenuates the Development of Pressure-Overload Hypertrophy , 2001, Circulation.

[25]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Hayward,et al.  Gender-related differences in left ventricular chamber function. , 2001, Cardiovascular research.

[27]  B. Katzenellenbogen,et al.  Estrogen receptor transcription and transactivation Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer , 2000, Breast cancer research : BCR.

[28]  C. di Loreto,et al.  Myocyte death in the failing human heart is gender dependent. , 1999, Circulation research.

[29]  P. Douglas,et al.  Gender differences in molecular remodeling in pressure overload hypertrophy. , 1999, Journal of the American College of Cardiology.

[30]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Hajjar,et al.  Apoptosis in the failing heart. , 1998, Cardiology clinics.

[32]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[33]  P. Douglas,et al.  Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. , 1998, Journal of the American College of Cardiology.

[34]  S. Kharbanda,et al.  Apoptosis and the heart. , 1997, Chest.

[35]  R. Karas,et al.  Cardiac myocytes and fibroblasts contain functional estrogen receptors 1 , 1997, FEBS letters.

[36]  E. Lakatta,et al.  Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. , 1997, The American journal of physiology.

[37]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[38]  E. Fleck,et al.  Isolation and characterisation of human cardiac fibroblasts from explanted adult hearts , 1996, Cell and Tissue Research.

[39]  O. Hess,et al.  Sex-dependent differences in left ventricular function and structure in chronic pressure overload. , 1995, European heart journal.

[40]  P. Anversa,et al.  Gender differences and aging: effects on the human heart. , 1995, Journal of the American College of Cardiology.

[41]  G. Aurigemma,et al.  Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. , 1995, Cardiology.

[42]  P. Buttrick,et al.  Sex-associated differences in left ventricular function in aortic stenosis of the elderly. , 1992, Circulation.

[43]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[44]  S. Shroff,et al.  Fibrillar Collagen and Myocardial Stiffness in the Intact Hypertrophied Rat Left Ventricle , 1989, Circulation research.

[45]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.